Metagenomi, Inc. - Common Stock (MGX)

Metagenomi, Inc. is a biotechnology company focused on the advancement of gene editing technologies for therapeutic applications

With a strong emphasis on leveraging its proprietary genomic tools, the company aims to develop novel treatments for genetic disorders and other complex diseases. Metagenomi's innovative approach combines advanced bioengineering and synthetic biology to create precision therapies that can effectively address a wide range of medical challenges. Through rigorous research and collaboration with leading scientific institutions, Metagenomi is dedicated to transforming the landscape of gene therapy and improving patient outcomes.